A double-blind, randomized, controlled parallel group study evaluating the efficacy and safety of acemetacin for the management of osteoarthritis

International Journal of Clinical Pharmacology Research

Volumn 22, Issue 1, 2002, Pages 1-6

  Chou, Chung Tei ^a   Tsai, Y Y ^a  

^a NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACEMET; ACEMETACIN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EDEMA; EYE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MALE; MICTURITION DISORDER; NAUSEA; OCCULT BLOOD; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIAL; RASH; STOMACH PAIN; SYNCOPE; TASTE DISORDER; TINNITUS; ULCER; VERTIGO; VISUAL ANALOG SCALE; VOMITING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; OSTEOARTHRITIS; OUTPATIENTS; TREATMENT OUTCOME;

EID: 0036397687     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Badia-Flores J., Munoz Barradas F. The treatment of rheumatoid arthritis with acemetacin and indomethacin. Arzneimittelforschung., 30(8a), 1433, 1980.
2. Kronhagel R. Clinical results of a double blind study with the new antirheumatic agent acemetacin. Arzneimittelforschung., 30(8a), 1445, 1980.
3. Uthgenannt H., Mohing W., Kohler G., Schmidt F., Havemann R. The influence of acemetacin and indomethacin on gastrointestinal blood loss in normal volunteers and rheumatic patients. Arzneimittelforschung., 30(8a), 1424, 1980.
4. Kronhagel R. Controlled trials of acemetacin versus piroxicam in osteoarthritis. Br. J. Clin. Pract., 40(11), 472, 1986.
5. Rechziegler H., Zundorf P. Acemetacin in treatment of rheumatic diseases: an open, multi-center trial. Curr. Med. Res. Opin., 9(10), 701, 1985.
6. Dell H.D., Doersing M., Fischer W., et al. Metabolism and pharmacokinetics of acemetacin in man. Arzneimittelforschung., 30(8a), 1391, 1980.
7. Neugirg R., Penners R. Clinical trials with acemetacin on children and adolescents. Arzneimittelforschung., 30(8a), 1451, 1980.
8. Teixeira F., Porto A., Moura J. Efficacy of a single daily dose of a nonsteroidal anti-inflammatory drug with an intermediate plasma half-life: a double-blind, comparative trial of acemetacin and piroxicam. Curr. Ther. Res., 53(1), 103, 1993.
9. Hazleman B., Bernstein R.M. Acemetacin in the long-term therapy of rheumatoid arthritis. Curr. Med. Res. Opin., 13(2), 119, 1993.
10. Saul P.A., Korlipara K. Acemetacin and indomethacin in the treatment of rheumatoid arthritis: a double-blind comparative study in general practice. Curr. Med. Res. Opin., 12(5), 332, 1991.
11. Jones R.W., Collins A.J., Notorianni L.J., Sedman E. The comparative phamiacokinetics of acemetacin in young subjects and elderly patients. Br. J. Clin. Pharmacol., 31, 543, 1991.
12. Acemetacin (Emflex) - yet another NSAID. Drug Ther. Bull., 29(20), 78, 1991.
13. Lee S.H., Soyoola E., Chanmugam R, et al. Selective expression of mitogen-inducible cyclooxgenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem., 267, 25934, 1992.
14. Tavares I. A., Bennett A. Acemetacin and indomethacin: Differential inhibition of constitutive and inducible cyclo-oxygenase in human gastric mucous and leukocytes. Int. J. Tissue Reac., 15(2), 49, 1993.
15. Jones R.W., Collins A.J., Notarianni L.J., Sedman E. The pharmacokinetics of acemetacin following single dosage to elderly volunteers. Clin. Exp. Rheumatol., 5(Suppl. 2), 268, 1987.